Nuo Therapeutics, Inc. (AURX) › Net IncomeNuo Therapeutics, Inc. (AURX) — Net IncomeAnnual figures by fiscal year, from SEC filings.2010: -$6.82M2011: -$3.51M2012: -$19.80M2013: -$20.25M2014: -$18.88M2015: -$52.81M2017: -$14.98M2018: -$1.54M2019: -$1.19M2020: -$90.9K2021: -$90.7K2022: -$3.17M2023: -$3.17M2024: -$2.32M2025: -$2.51M-$2.51M2010Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$2.51M-8.1%2024-$2.32M+26.7%2023-$3.17M+0.0%2022-$3.17M-3398.1%2021-$90.7K+0.2%2020-$90.9K+92.4%2019-$1.19M+22.5%2018-$1.54M+89.7%2017-$14.98M—2015-$52.81M-179.7%2014-$18.88M+6.7%2013-$20.25M-2.3%2012-$19.80M-464.0%2011-$3.51M+48.5%2010-$6.82M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share